Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.170
+0.060 (1.93%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Niagen Bioscience Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 129.08 | 129.42 | 99.6 | 83.57 | 72.05 | 67.45 |
Revenue Growth | 10.99% | 29.95% | 19.18% | 15.99% | 6.82% | 13.83% |
Gross Profit Gross Profit Growth | 82.92 | 83.19 | 61.59 | 50.78 | 42.8 | 41.49 |
Operating Income Operating Income Growth | 8.62 | 14.3 | 7.73 | -5.6 | -18.63 | -27.07 |
Net Income Net Income Growth | 15.99 | 17.38 | 8.55 | -4.94 | -16.54 | -27.13 |
Earnings Per Share EPS Growth | 0.19 | 0.20 | 0.11 | -0.07 | -0.24 | -0.40 |
EPS Growth | -11.65% | 81.82% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Consumer Products Consumer Products Growth | 100.05 | 97.67 | 76.77 | 69.53 | 60.11 | 56.71 |
Ingredients Ingredients Growth | 26.84 | 28.68 | 19.81 | 11.14 | 8.74 | 7.41 |
Analytical Reference Standards and Services Analytical Reference Standards and Services Growth | 1.89 | 3.08 | 3.01 | 2.91 | 3.2 | 3.34 |
Total Total Growth | 129.08 | 129.42 | 99.6 | 83.57 | 72.05 | 67.45 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 66.59 | 64.64 | 44.51 | 27.17 | 20.29 | 28.02 |
Total Debt Total Debt Growth | 2.33 | 2.82 | 2.65 | 3.28 | 4.26 | 4.7 |
Net Cash (Debt) Net Cash Growth | 64.26 | 61.82 | 41.86 | 23.9 | 16.03 | 23.32 |
Net Cash Growth | 12.68% | 47.69% | 75.16% | 49.05% | -31.24% | 56.91% |
Net Cash Per Share Net Cash Per Share Growth | 0.76 | 0.72 | 0.54 | 0.32 | 0.23 | 0.35 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 5.95 | 13.5 | 12.11 | 7.12 | -15.1 | -24.16 |
Capital Expenditures CapEx Growth | -0.28 | -0.29 | -0.16 | -0.15 | -0.33 | -0.41 |
Free Cash Flow Free Cash Flow Growth | 5.67 | 13.21 | 11.95 | 6.97 | -15.43 | -24.57 |
Free Cash Flow Growth | -72.90% | 10.60% | 71.42% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 64.24% | 64.28% | 61.83% | 60.76% | 59.40% | 61.51% |
Operating Margin | 6.67% | 11.05% | 7.76% | -6.70% | -25.85% | -40.14% |
Pretax Margin | 13.19% | 14.06% | 8.89% | -5.91% | -22.96% | -40.22% |
Profit Margin | 12.39% | 13.43% | 8.58% | -5.91% | -22.96% | -40.22% |
FCF Margin | 4.40% | 10.21% | 11.99% | 8.34% | -21.42% | -36.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.67 | 29.26 | 47.50 | - | - | - |
Forward PE | 34.46 | 27.81 | 50.28 | 160.00 | 160.00 | 160.00 |
P/FCF Ratio | 44.30 | 38.50 | 33.99 | 15.45 | - | - |
PS Ratio | 1.95 | 3.93 | 4.08 | 1.29 | 1.74 | 3.79 |